A leading partner in strategy and innovation, we empower life sciences teams with cutting-edge services and AI-driven tools.
We put our clients at the center of everything we do — responding quickly, adapting easily, and always aiming to exceed expectations.
We bring a positive, solution-oriented mindset backed by structure, critical thinking, and evidence-based work.
We lead with authenticity, empathy, and respect, building trust through every interaction.
We’re resilient, curious, and committed to continuous learning — always raising the bar to deliver best-in-class results.
Founded to rethink the consultancy model. Princeton Biopartners began as a family-run strategy firm with a clear mission: to replace transactional vendor relationships with true strategic partnership. From day one, we worked as an embedded extension of biopharma teams, translating complex science into clear, actionable strategy and evidence plans that move the needle.
Our client-first approach fueled rapid expansion, driven almost entirely by referrals. That early momentum shaped one of our most important success metrics: client retention and referral rate. It remains at the core of how we measure impact today.
We launched our proprietary platform, EVEXA™, now recognized as the gold standard for Integrated Evidence Generation Planning. In parallel, we supported one of the most high-impact IEGPs in recent history with a leading innovator in COVID-19 therapeutics. These milestones solidified our role as the go-to partner for cross-functional evidence strategy.
Today, we work with some of the most innovative companies in biopharma, delivering integrated support across asset strategy, real-world evidence, HEOR, medical communications, and digital transformation. Our consulting and technology capabilities are built to work seamlessly together, from insight to execution.
With in-house teams across three continents and global execution experience, we meet clients where they are.
San Francisco
London
Princeton
Singapore
Taufi is the Founder and Managing Principal at Princeton Biopartners. Bringing over 20 years of combined pharmaceutical and consultancy experience, she offers deep global expertise in pharmaceutical marketing and strategy, spanning the full product lifecycle from prelaunch to end-of-life planning. Taufi is recognised for delivering impactful solutions that address complex market access and commercial challenges. Prior to Princeton, Taufi was the Director of Market Access and Emerging Markets at Bristol Myers Squibb. Taufi studied Biophysics at University College London.
Imanie is a Consultant at Princeton Biopartners, combining her passion for neurobiology with strategic expertise to deliver actionable solutions for life sciences clients. She leads end-to-end Medical Affairs projects, from strategy to execution, ensuring insight-driven results that meet complex scientific and commercial needs. Imanie studied Neuroscience at the University of Oxford, obtaining a first-class honor.
Natanya is an Analyst at Princeton Biopartners, combining her passion for immunology and oncology with analytical expertise to deliver strategic, actionable insights across client projects. She collaborates closely with the Princeton team to address complex scientific and commercial challenges. Prior to Princeton, she worked as a Researcher at Imperial College London with focus on clinical trials. Natanya studied Integrated Immunology at the University of Oxford, obtaining a Dsitinction, and Natural Sciences at the University of Cambridge, obtaining a first-class honor.
Beatrice is a Subject Matter Expert at Princeton Biopartners with over 20 years of experience in the pharmaceutical industry. Most recently, Beatrice was the VP of Global Compliance and Continuous Improvement at Bristol Myers Squibb, with focus on clinical trial management and strategy. Prior to Bristol-Myers, Beatrice worked as a clinician and HIV/AIDs researcher at Hôpitaux Universitaries Pitié Salpêtrière – Charles Foix. Beatrice holds an MD from the Pierre and Marie Curie University.
Alyssa is a Subject Matter Expert at Princeton Biopartners, bringing over a decade of expertise in machine learning and neuroscience to support life sciences projects. She leverages her deep scientific knowledge to deliver actionable insights that advance client strategies and innovation. Most recently, Alyssa serves as a Research Assistant Professor at The Icahn School of Medicine at Mount Sinai. She previously held postdoctoral research fellowships in Neuroscience at Princeton University and Molecular and Cellular Biology at Harvard University. Alyssa holds a PhD in Biophysics from Harvard University.
Connor is a Senior Consultant at Princeton Biopartners, specializing in dermatology and clinical science. He applies his clinical expertise to deliver strategic, actionable insights for life sciences clients, supporting complex scientific and commercial projects. He holds an MD from Columbia University Vagelos College of Physicians and Surgeons and studied Ecology and Evolutionary Biology at Princeton University.
Dillon is a Co-Founder and the Growth Lead at Princeton Biopartners. With over a decade of experience in biopharmaceutical strategy consulting and venture capital, Dillon brings a wealth of expertise. Prior experiences range from advising on go-to-market strategies for oncology therapies, to orchestrating growth-financing for MedTech companies. Dillon studied Biostatistics at King’s College London and Data Science at Harvard University.
Lisa is a Consultant at Princeton Biopartners, combining her scientific expertise with strategic consulting skills to deliver actionable solutions for life sciences clients. She leads and supports client engagements from strategy development through to execution, ensuring insight-driven recommendations that address complex scientific and commercial challenges. Lisa studied Pharmacology at the University of Cambridge and Medical Biosciences at Imperial College London, obtaining a first-class honor.
Ibraheem is the Software Engineer at Princeton Biopartners, where he oversees the execution of proprietary software initiatives and leads website development. He combines his technical expertise with innovative problem-solving to deliver impactful digital solutions for the firm. Previously, Ibraheem was a Software Engineer at Microsoft, working on Azure for Operators and Company Systems. He studied Maths at the University of Cambridge.
James is a Subject Matter Expert at Princeton Biopartners with a 20-year background in health economics. Most recently, Jim led global evidence generation for hematology CAR-T products and early pipeline development of solid tumor and autoimmune assets at Kite/Gilead. Prior to Gilead, Jim held similar health economics roles at Amgen, Genentech, Elan, and Abbott. Jim studied Immunology at Brown University and Cellular Biology at the University of Michigan.
Samantha is a Subject Matter Expert at Princeton Biopartners, bringing over 15 years of experience in drug development and translational research to advance life sciences projects. She leverages her deep industry knowledge to provide strategic insights that drive innovation and client success. Most recently, Samantha serves as Business Development Manager at the Experimental Drug Development Centre (EDDC) under A*STAR Singapore and is a founding Co-Managing Director of Nucleate (Singapore). She holds a PhD in Biological and Biomedical Sciences from Harvard Medical School.
We don’t do stagnation. From day one, you’ll gain direct exposure to client strategy, high-stakes decisions, and real intellectual ownership.
We are a deliberately lean, high-calibre team. Your work matters, your voice is heard, and your growth is prioritized.
Our performance cycles are built for development, not bureaucracy. They pair regular feedback with targeted mentorship.
Progression is fast-paced and merit-based. Compensation and benefits are positioned at the upper end of the consulting industry.
You will build lasting relationships with some of the most innovative players in pharma and biotech, becoming a true strategic partner rather than just a consultant.
Across engineering, business development, and strategy, we’re seeking people who share our commitment to driving
meaningful change in healthcare.
If you’re interested in joining our team, explore our open positions on LinkedIn.
